Sharescart Research Club logo ×
Screener Research Buy Unlisted Shares Sell Unlisted Shares Startup Funding New IPO New

RainbowChildrenS Med

₹1525.8 -15.7 | 1%

Market Cap ₹15495 Cr.

Stock P/E 63.4

P/B 10.6

Current Price ₹1525.8

Book Value ₹ 144.4

Face Value 10

52W High ₹1708.5

Dividend Yield 0.2%

52W Low ₹ 1079.3

Overview Inc. Year: 1998Industry: Hospital & Healthcare Services

Rainbow Children’s Medicare Ltd is a multi-speciality obstetrics, paediatric and gynaecology hospital chain in India. The agency’s infant health offerings consist of general paediatrics, neonatalogy, surgical treatment, gastroenterology and liver sicknesses, haematology and oncology, psychology, dentistry, pulmonology, endocrinology, nephrology, nutrients, psychiatry, ENT, cardiology, radiology, physiotherapy and rehabilitation, orthopaedics, urology, ophthalmology, dermatology, allergy, neurosurgery, rheumatology, infectious disorder, and cranio-maxillofacial surgical procedure; extensive care unit, bone marrow transplant unit, anesthesia and pain control, kidney transplant, cochlear implant services; genetics and metabolic drug treatments; and laboratory, speech and language remedy, occupational therapy, paediatric and metabolic medication, developmental and behavioural paediatrics, cerebral palsy care offerings. Its women health services comprises obstetrics and gynaecology, painless delivery and labor, high risk being pregnancy and delivery, childbirth preparation lessons, vaginal birth after cesarean, breast feeding assist, well women checkup, urogynecology, pre-pregnancy health checkup, minimally invasive surgery, breast care, fetal medicinal drug, menopausal treatment, new-born care, ladies's nutrients, and diabetology. The business enterprise additionally gives fertility care offerings, inclusive of fertility remedy, ovulation induction, intracytoplasmic sperm injection treatment, investigation, intrauterine insemination, intracytoplasmic morphologically selected sperm injection, assisted hatching, cryopreservation, sperm and oocyte donor remedies, frozen embryo switch, surgical sperm retrieval, embryo donor remedies, reproductive surgery, pre-conception counselling, and andrology and urology. As of December 31, 2021, it operated 14 hospitals and three clinics in 6 towns with a total of 1500 beds. The enterprise incorporated in 1998 and is primarily based in Hyderabad, India.

Read More..

RainbowChildrenS Med Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

RainbowChildrenS Med Quarterly Results

#(Fig in Cr.) Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 306 317 287 333 336 341 330 417 398 370
Other Income 8 9 8 8 9 13 12 11 13 15
Total Income 315 326 295 340 345 354 342 429 411 385
Total Expenditure 200 219 199 215 218 236 236 270 264 255
Operating Profit 115 107 96 125 127 118 106 158 148 129
Interest 14 14 15 13 14 17 18 18 18 18
Depreciation 23 23 25 27 28 32 34 35 35 34
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 78 70 56 85 85 69 53 105 94 77
Provision for Tax 20 16 14 22 22 18 14 26 25 20
Profit After Tax 58 54 41 63 63 51 40 79 69 57
Adjustments -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
Profit After Adjustments 58 54 41 63 62 51 40 79 69 56
Adjusted Earnings Per Share 5.7 5.3 4 6.2 6.1 5 3.9 7.8 6.8 5.5

RainbowChildrenS Med Profit & Loss

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 321 402 543 719 650 974 1174 1297 1516 1515
Other Income 11 10 8 10 10 19 31 37 51 51
Total Income 332 411 551 730 660 993 1204 1334 1567 1567
Total Expenditure 266 332 431 519 485 666 774 865 1022 1025
Operating Profit 66 79 120 211 175 327 430 469 545 541
Interest 3 4 6 48 46 56 58 63 77 72
Depreciation 22 28 37 69 73 83 90 112 138 138
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 41 47 78 93 56 187 282 295 330 329
Provision for Tax 10 11 20 38 16 49 69 77 86 85
Profit After Tax 31 36 58 55 40 139 212 218 244 245
Adjustments 0 0 0 0 0 -0 -2 -1 -1 0
Profit After Adjustments 31 36 58 56 40 138 211 217 243 244
Adjusted Earnings Per Share 3.4 4 6.4 6.2 4.4 14.7 20.8 21.4 24 24

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 17% 16% 16% 0%
Operating Profit CAGR 16% 19% 21% 0%
PAT CAGR 12% 21% 35% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 21% 47% NA% NA%
ROE Average 18% 21% 20% 17%
ROCE Average 30% 34% 33% 27%

RainbowChildrenS Med Balance Sheet

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 329 362 416 405 446 603 1060 1259 1468
Minority's Interest 0 0 0 4 2 3 5 6 7
Borrowings 10 10 50 46 41 27 0 0 0
Other Non-Current Liabilities 4 5 7 472 468 526 541 730 722
Total Current Liabilities 56 70 86 171 122 125 139 149 151
Total Liabilities 399 448 559 1098 1078 1284 1745 2144 2347
Fixed Assets 174 296 344 702 772 858 931 1253 1398
Other Non-Current Assets 100 79 78 153 109 136 336 270 127
Total Current Assets 126 73 136 244 197 290 478 622 822
Total Assets 399 448 559 1098 1078 1284 1745 2144 2347

RainbowChildrenS Med Cash Flow

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 4 5 3 5 7 6 10 17 10
Cash Flow from Operating Activities 36 48 90 170 143 224 329 321 396
Cash Flow from Investing Activities -33 -42 -117 -117 -83 -175 -465 -226 -268
Cash Flow from Financing Activities -1 -7 28 -52 -61 -44 143 -102 -118
Net Cash Inflow / Outflow 1 -2 2 2 -1 4 7 -7 10
Closing Cash & Cash Equivalent 5 3 5 7 6 10 17 10 20

RainbowChildrenS Med Ratios

# Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 3.43 3.96 6.4 6.18 4.44 14.7 20.77 21.38 23.97
CEPS(Rs) 5.9 7.14 10.52 13.84 12.53 23.6 29.82 32.55 37.68
DPS(Rs) 2.5 1 1 2 0 2 3 3 3
Book NAV/Share(Rs) 35.24 38.93 44.88 43.77 48.32 62.93 104.42 123.08 144.41
Core EBITDA Margin(%) 17.1 17.3 20.61 27.9 25.4 31.61 34.05 33.34 32.6
EBIT Margin(%) 13.74 12.7 15.35 19.69 15.7 25.01 28.99 27.55 26.84
Pre Tax Margin(%) 12.84 11.64 14.3 12.98 8.57 19.24 24.01 22.73 21.77
PAT Margin (%) 9.76 9.03 10.67 7.69 6.09 14.24 18.1 16.83 16.11
Cash Profit Margin (%) 16.57 16.02 17.47 17.34 17.37 22.79 25.79 25.47 25.24
ROA(%) 7.86 8.57 11.51 6.68 3.64 11.74 14.02 11.23 10.87
ROE(%) 9.87 10.85 15.34 13.85 9.54 27 25.72 18.91 17.99
ROCE(%) 12.83 14.2 19.81 30.56 21.42 42.92 39.96 30.82 29.83
Receivable days 15.54 13.2 14.78 18.4 24.69 15.81 14.24 17.12 17.79
Inventory Days 7.65 5.78 4.36 5.83 7.32 4.67 5.22 6.01 6.21
Payable days 142.04 134.98 134.76 161.38 197.76 110.68 165.2 177.11 161.48
PER(x) 0 0 0 0 0 0 35.16 60.71 58.39
Price/Book(x) 0 0 0 0 0 0 6.99 10.55 9.69
Dividend Yield(%) 0 0 0 0 0 0 0.41 0.23 0.21
EV/Net Sales(x) -0.16 0.08 0.06 0.02 0.01 -0.04 6.28 10.15 9.36
EV/Core EBITDA(x) -0.8 0.41 0.25 0.06 0.03 -0.12 17.11 28.04 26.03
Net Sales Growth(%) 0 25.07 35.08 32.54 -9.64 49.8 20.52 10.51 16.88
EBIT Growth(%) 0 15.65 63.19 69.99 -27.93 138.58 39.69 5.05 13.84
PAT Growth(%) 0 15.74 59.67 -4.47 -28.5 250.47 53.15 2.78 11.88
EPS Growth(%) 0 15.65 61.61 -3.41 -28.19 231.04 41.3 2.93 12.12
Debt/Equity(x) 0.05 0.04 0.12 0.14 0.1 0.07 0 0 0
Current Ratio(x) 2.26 1.03 1.58 1.42 1.61 2.32 3.44 4.16 5.46
Quick Ratio(x) 2.14 0.95 1.5 1.33 1.53 2.2 3.31 4 5.28
Interest Cover(x) 15.25 11.96 14.64 2.93 2.2 4.34 5.83 5.71 5.3
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0

RainbowChildrenS Med Shareholding Pattern

# Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Promoter 49.83 49.83 49.83 49.83 49.83 49.83 49.88 49.85 49.85 49.85
FII 20.81 19.82 20.19 21.63 22.32 24.04 24.78 25.11 25.12 23.69
DII 13.9 15.38 15.35 15.4 15.62 14.76 13.8 13.83 13.87 15.31
Public 15.46 14.97 14.63 13.14 12.23 11.37 11.54 11.2 11.16 11.14
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 34% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 21%
  • Debtor days have improved from 177.11 to 161.48days.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 49.85%.
  • Stock is trading at 10.6 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

RainbowChildrenS Med News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....